Cargando…

Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data

BACKGROUND: In astigmatism clinical trials where more complex measurements are common, especially in nonrandomized small sized clinical trials, there is a demand for the development and application of newer statistical methods. METHODS: The source data belonged to a project on astigmatism treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Sedghipour, Mohammad Reza, Sadeghi-Bazargani, Homayoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460701/
https://www.ncbi.nlm.nih.gov/pubmed/23055670
http://dx.doi.org/10.2147/OPTH.S34907
_version_ 1782244966891782144
author Sedghipour, Mohammad Reza
Sadeghi-Bazargani, Homayoun
author_facet Sedghipour, Mohammad Reza
Sadeghi-Bazargani, Homayoun
author_sort Sedghipour, Mohammad Reza
collection PubMed
description BACKGROUND: In astigmatism clinical trials where more complex measurements are common, especially in nonrandomized small sized clinical trials, there is a demand for the development and application of newer statistical methods. METHODS: The source data belonged to a project on astigmatism treatment. Data were used regarding a total of 296 eyes undergoing different astigmatism treatment modalities: wavefront-guided photorefractive keratectomy, cross-cylinder photorefractive keratectomy, and monotoric (single) photorefractive keratectomy. Astigmatism analysis was primarily done using the Alpins method. Prior to fitting partial least squares regression discriminant analysis, a preliminary principal component analysis was done for data overview. Through fitting the partial least squares regression discriminant analysis statistical method, various model validity and predictability measures were assessed. RESULTS: The model found the patients treated by the wavefront method to be different from the two other treatments both in baseline and outcome measures. Also, the model found that patients treated with the cross-cylinder method versus the single method didn’t appear to be different from each other. This analysis provided an opportunity to compare the three methods while including a substantial number of baseline and outcome variables. CONCLUSION: Partial least squares regression discriminant analysis had applicability for the statistical analysis of astigmatism clinical trials and it may be used as an adjunct or alternative analysis method in small sized clinical trials.
format Online
Article
Text
id pubmed-3460701
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-34607012012-10-09 Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data Sedghipour, Mohammad Reza Sadeghi-Bazargani, Homayoun Clin Ophthalmol Original Research BACKGROUND: In astigmatism clinical trials where more complex measurements are common, especially in nonrandomized small sized clinical trials, there is a demand for the development and application of newer statistical methods. METHODS: The source data belonged to a project on astigmatism treatment. Data were used regarding a total of 296 eyes undergoing different astigmatism treatment modalities: wavefront-guided photorefractive keratectomy, cross-cylinder photorefractive keratectomy, and monotoric (single) photorefractive keratectomy. Astigmatism analysis was primarily done using the Alpins method. Prior to fitting partial least squares regression discriminant analysis, a preliminary principal component analysis was done for data overview. Through fitting the partial least squares regression discriminant analysis statistical method, various model validity and predictability measures were assessed. RESULTS: The model found the patients treated by the wavefront method to be different from the two other treatments both in baseline and outcome measures. Also, the model found that patients treated with the cross-cylinder method versus the single method didn’t appear to be different from each other. This analysis provided an opportunity to compare the three methods while including a substantial number of baseline and outcome variables. CONCLUSION: Partial least squares regression discriminant analysis had applicability for the statistical analysis of astigmatism clinical trials and it may be used as an adjunct or alternative analysis method in small sized clinical trials. Dove Medical Press 2012 2012-09-18 /pmc/articles/PMC3460701/ /pubmed/23055670 http://dx.doi.org/10.2147/OPTH.S34907 Text en © 2012 Sedghipour and Sadeghi-Bazargani, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Sedghipour, Mohammad Reza
Sadeghi-Bazargani, Homayoun
Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data
title Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data
title_full Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data
title_fullStr Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data
title_full_unstemmed Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data
title_short Applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data
title_sort applicability of supervised discriminant analysis models to analyze astigmatism clinical trial data
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460701/
https://www.ncbi.nlm.nih.gov/pubmed/23055670
http://dx.doi.org/10.2147/OPTH.S34907
work_keys_str_mv AT sedghipourmohammadreza applicabilityofsuperviseddiscriminantanalysismodelstoanalyzeastigmatismclinicaltrialdata
AT sadeghibazarganihomayoun applicabilityofsuperviseddiscriminantanalysismodelstoanalyzeastigmatismclinicaltrialdata